The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.  

  •  

    DEPARTMENT OF HEALTH

    Board of Medicine

    RULE NO.:RULE TITLE:

    64B8-9.0141Standards for Telemedicine Practice

    PURPOSE AND EFFECT: The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.

    SUBJECT AREA TO BE ADDRESSED: The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.

    RULEMAKING AUTHORITY: 458.331(1)(v) FS.

    LAW IMPLEMENTED: 458.331(1)(v) FS.

    IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Adrienne Rodgers, Interim Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253

    THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.

Document Information

Subject:
The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
Purpose:
The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
Rulemaking Authority:
458.331(1)(v), FS.
Law:
458.331(1)(v), FS.
Contact:
Adrienne Rodgers, Interim Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253.
Related Rules: (1)
64B8-9.0141. Standards for Telemedicine Practice